FR – Hexal and Sandoz v. Boehringer Ingelheim Pharma

Posted: July 8th, 2010

Hexal A.G. and SAS Sandoz v. Boehringer Ingelheim Pharma GbmH & CoKG, Tribunal de Grande Instance, Paris, France, 7 May 2010, Docket No. 08/12537, with thanks to Pierre Véron, Véron & Associés for sending in the case and the translation In a case dealing with the use of (S)(+)-2-ethoxy-4-[N-[1-(2-piperidinophenyl)-3-methyl-1-butyl]aminocarbonylmethyl]-benzoic acid as the active principle in a […]


NL – Gebr. Ezendam v. Lommers-Van Eijken Tuinbouwmachines

Posted: April 2nd, 2010

Vastgoedmaatschappij Gebr. Ezendam B.V. v. Lommers-Van Eijken Tuinbouwmachines B.V., District Court The Hague, The Netherlands, 31 March 2010, Case No. 2009/2379
The District Court of the Hague ruled that Dutch part of Ezendam’s European patent on the use of a cutting cylinder unit, cutting device with cutting cylinder unit for shaping a plant,


NL – Ratiopharm v. Eli Lilly / Olanzapine patent invalid

Posted: April 1st, 2010

Olanzapine Ratiopharm GmbH, Ratiopharm Nederland B.V., Ratiopharm B.V. v. Eli Lilly and Co Ltd., District Court The Hague, The Netherlands, 24 March 2010, Case No. 2008/2126, with thanks to Chantal Morel & Moïra Truijens, Klos Morel Vos & Schaap
The Dutch part of Eli Lilly’s patent and SPC re olanzapine was found to be invalid


NL – WDS Luxe v. Spant Best B.V. (Plameco)

Posted: January 13th, 2010

WDS Luxe B.V.v. Joseph Spanjers and Spant Best B.V., h.o.d.n. Plameco, The Hague District Court, The Netherlands, 13 January 2010, Docket No. 336602 / HA ZA 09-1505
Claim 1 of EP 308 is not novel over the Tombu patent. No violation of the principles of due process due to


UK – Dr Reddy’s Laboratories v. Eli Lilly and Company Limited / Olanzapine

Posted: December 18th, 2009

Dr Reddy’s Laboratories (UK) Limited v. Eli Lilly and Company Limited, Court of Appeal (Civil Division), UK, 18 December 2009, Docket No: Case No.A3/2008/2966, with thanks to Robert Fitt, Bristows The Court of Appeal upheld the decision of Mr Justice Floyd and confirmed that Lilly’s (selection) patent concerning the drug olanzapine is valid. Olanzapine is […]


DE – Leistungshalbleiterbauelement / opposition

Posted: July 30th, 2009

Leistungshalbleiterbauelement (High performance semiconductor component), opposition proceedings (admissibility of an opposition), Federal Supreme Court, Germany, 30 July 2009, Docket No. Xa. ZB 28/08 If a party files an opposition against a patent based on a prior application which cannot be considered for the assessment of inventive step, the opposition is admissible even if the party […]